SPARC Sun Pharma Advanced Research Company Ltd Litigation, disputes or regulatory action Announcement 2023 - Regulatory Compliance FDA issues complete response letter for PDP -716 NDA due to inspection findings at third-party API manufacturing facility.Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Sun Pharma Advanced Research Company Ltd